Coal tar litigation
This article was originally published in The Rose Sheet
Executive SummaryState of California, Tegrin dandruff shampoo marketer Reedco reach tentative settlement in Prop 65 coal tar litigation. Trial against Reedco, a subsidiary of GlaxoSmithKline's Block Drug and the sole remaining defendant in the litigation, had been scheduled for May 13. Settlement is similar to those by other manufacturers, marketers of coal-tar containing shampoos and creams who agreed to place warnings on certain products, pay monetary penalties ranging from a few thousand to several hundred thousand dollars (1"The Rose Sheet" Feb. 18, 2002, In Brief)...
You may also be interested in...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced October to November.
The French drugmaker is paying $2.5bn to get hold of THOR-707 which it claims has the potential to become the best-in-class IL-2 therapeutic for solid tumors, thanks to improved pharmacology and less frequent dosing.
For the first time, a working group within the International Council for Harmonization has started work on a regulatory topic specifically tailored to the global generics and biosimilars industry.